Cadila Healthcare informs about press release

03 Nov 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated November 3, 2020 titled ‘Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

889.95 -0.25 (-0.03%)
30-Jan-2026 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1591.00
Dr. Reddys Lab 1216.00
Cipla 1323.00
Zydus Lifesciences 889.95
Lupin 2151.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×